BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26483195)

  • 1. Risk factors for post-transplant diabetes mellitus in renal transplant: Role of genetic variability in the CYP450-mediated arachidonic acid metabolism.
    Gervasini G; Luna E; García-Cerrada M; García-Pino G; Cubero JJ
    Mol Cell Endocrinol; 2016 Jan; 419():158-64. PubMed ID: 26483195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in CYP-mediated arachidonic acid routes affect the outcome of renal transplantation.
    Gervasini G; García-Cerrada M; Vergara E; García-Pino G; Alvarado R; Fernández-Cavada MJ; Barroso S; Doblaré E; Cubero JJ
    Eur J Clin Invest; 2015 Oct; 45(10):1060-8. PubMed ID: 26214067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in vasoactive eicosanoid genes of kidney donors affect biopsy scores and clinical outcomes in renal transplantation.
    Mota-Zamorano S; González LM; Luna E; Fernández JJ; Gómez Á; Nieto-Fernández A; Robles NR; Gervasini G
    PLoS One; 2019; 14(10):e0224129. PubMed ID: 31622444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in the leptin receptor gene and other risk factors for post-transplant diabetes mellitus in renal transplant recipients.
    Mota-Zamorano S; Luna E; Garcia-Pino G; González LM; Gervasini G
    Ann Med; 2019 Mar; 51(2):164-173. PubMed ID: 31046466
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus.
    Lancia P; Adam de Beaumais T; Elie V; Garaix F; Fila M; Nobili F; Ranchin B; Testevuide P; Ulinski T; Zhao W; Deschênes G; Jacqz-Aigrain E
    Pediatr Nephrol; 2018 Jun; 33(6):1045-1055. PubMed ID: 29399716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in genes involved in vasoactive eicosanoid synthesis affect cardiovascular risk in renal transplant recipients.
    Gervasini G; Luna E; Garcia-Pino G; Azevedo L; Mota-Zamorano S; José Cubero J
    Curr Med Res Opin; 2018 Feb; 34(2):247-253. PubMed ID: 29022765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel CYP4F2 genetic variants exhibiting decreased catalytic activity in the conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE).
    Kim WY; Lee SJ; Min J; Oh KS; Kim DH; Kim HS; Shin JG
    Prostaglandins Leukot Essent Fatty Acids; 2018 Apr; 131():6-13. PubMed ID: 29628049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients.
    Numakura K; Satoh S; Tsuchiya N; Horikawa Y; Inoue T; Kakinuma H; Togashi H; Matsuura S; Tada H; Suzuki T; Habuchi T
    Transplant Proc; 2005 May; 37(4):1865-7. PubMed ID: 15919487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus.
    Numakura K; Satoh S; Tsuchiya N; Horikawa Y; Inoue T; Kakinuma H; Matsuura S; Saito M; Tada H; Suzuki T; Habuchi T
    Transplantation; 2005 Nov; 80(10):1419-24. PubMed ID: 16340785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11.
    Powell PK; Wolf I; Jin R; Lasker JM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1327-36. PubMed ID: 9618440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum magnesium, hepatocyte nuclear factor 1β genotype and post-transplant diabetes mellitus: a prospective study.
    van der Burgh AC; Moes A; Kieboom BCT; van Gelder T; Zietse R; van Schaik RHN; Hesselink DA; Hoorn EJ
    Nephrol Dial Transplant; 2020 Jan; 35(1):176-183. PubMed ID: 31361318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional polymorphism in human CYP4F2 decreases 20-HETE production.
    Stec DE; Roman RJ; Flasch A; Rieder MJ
    Physiol Genomics; 2007 Jun; 30(1):74-81. PubMed ID: 17341693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a single nucleotide polymorphism of the CYP4F2 gene on blood pressure and 20-hydroxyeicosatetraenoic acid excretion after weight loss.
    Ward NC; Croft KD; Puddey IB; Phillips M; van Bockxmeer F; Beilin LJ; Barden AE
    J Hypertens; 2014 Jul; 32(7):1495-502; discussion 1502. PubMed ID: 24984178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher initial tacrolimus blood levels and concentration-dose ratios in kidney transplant recipients who develop diabetes mellitus.
    Rodrigo E; de Cos MA; Fernández-Fresnedo G; Sánchez B; Ruiz JC; Piñera C; Palomar R; Cotorruelo JG; Gómez-Alamillo C; de Castro SS; de Francisco AL; Arias M
    Transplant Proc; 2005 Nov; 37(9):3819-20. PubMed ID: 16386549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years.
    Cosio FG; Pesavento TE; Osei K; Henry ML; Ferguson RM
    Kidney Int; 2001 Feb; 59(2):732-7. PubMed ID: 11168956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intakes of omega-3 polyunsaturated fatty acids and blood pressure change over time: Possible interaction with genes involved in 20-HETE and EETs metabolism.
    Tagetti A; Ericson U; Montagnana M; Danese E; Almgren P; Nilsson P; Engström G; Hedblad B; Minuz P; Orho-Melander M; Fava C; Melander O
    Prostaglandins Other Lipid Mediat; 2015 Jul; 120():126-33. PubMed ID: 25986600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant diabetes mellitus: is it associated with poor allograft outcomes in renal transplants?
    Choi JY; Kwon OJ
    Transplant Proc; 2013 Oct; 45(8):2892-8. PubMed ID: 24156999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
    Gnatta D; Keitel E; Heineck I; Cardoso BD; Rodrigues AP; Michel K; Garcia VD
    Transplant Proc; 2010 Mar; 42(2):475-8. PubMed ID: 20304169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of posttransplantation diabetes mellitus during follow-up in kidney transplant recipients and relationship to Fok1 vitamin D receptor polymorphism.
    Yao B; Chen X; Shen FX; Xu W; Dong TT; Chen LZ; Weng JP
    Transplant Proc; 2013; 45(1):194-6. PubMed ID: 23375298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure.
    Ward NC; Tsai IJ; Barden A; van Bockxmeer FM; Puddey IB; Hodgson JM; Croft KD
    Hypertension; 2008 May; 51(5):1393-8. PubMed ID: 18391101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.